Tina Hartwright focuses her practice on private equity and corporate transactions, advising private equity sponsors, corporates and founders on complex domestic and cross-border matters. Her experience spans M&A, carve-outs, co-investments, minority deals, public-to-privates, restructurings, joint ventures, “buy-and-build” strategies and other strategic transactions, as well as a wide range of general corporate matters. Tina regularly advises clients on high-value and strategically significant mandates, helping them navigate complex matters from inception through to completion.
Tina advises clients across a broad range of sectors, with particular experience in healthcare, life sciences, defence, insurance, financial institutions, aviation, infrastructure, industrials and consumer businesses.
- Advised various founders on the sale of Rotron, a leading developer of advanced unmanned aerial systems and long-range autonomous platforms, to Ondas, Inc.
- Advised Northcote Equity on the purchase of Nuvo Accounting.
- Advised Novartis, a Swiss pharmaceutical company, on the disposal of CELLforCure and its cell & gene therapy development and production site in Les Ulis, France to Seqens SAS.
- Advised on the development of the offtake and pricing framework for one of the world’s leading integrated rare earths projects, including arrangements for the sale and commercialization of mixed rare earth concentrate and downstream products.
- Advised Novartis on M&A matters in Germany and France*
- BPP Law School, LPC, Distinction
- University of Warwick, LLB, First Class Honours
- England and Wales